Tandem Diabetes Care (TNDM) COO logs RSU vesting, 31,741 shares held after tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tandem Diabetes Care EVP & Chief Operating Officer Jean-Claude Kyrillos reported equity compensation activity. On July 15, 2026, 3,636 restricted stock units converted into common stock, bringing his direct holdings to 31,741 shares. To satisfy tax withholding on the vesting, the company withheld 1,926 shares at $15.28 per share; no shares were sold in the market. After this vesting, 14,545 RSUs from a July 2024 grant under the 2023 Long-Term Incentive Plan remain outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,636 shares exercised/converted
Mixed
3 txns
Insider
Kyrillos Jean-Claude
Role
EVP & Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 3,636 | $0.00 | -- |
| Exercise | Common Stock | 3,636 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,926 | $15.28 | $29K |
Holdings After Transaction:
Restricted Stock Unit — 14,545 shares (Direct);
Common Stock — 31,741 shares (Direct)
Footnotes (1)
- Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. One-third of the RSUs granted on July 14, 2024 vested on July 14, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Key Figures
Shares withheld for taxes: 1926.0000 shares
Tax withholding price: $15.2800 per share
Shares from RSU conversion: 3636.0000 shares
+3 more
6 metrics
Shares withheld for taxes
1926.0000 shares
Common stock withheld to satisfy tax withholding requirements on RSU vesting
Tax withholding price
$15.2800 per share
Value used for shares withheld to cover tax obligations
Shares from RSU conversion
3636.0000 shares
Common shares acquired upon exercise/conversion of restricted stock units
Common shares after transactions
31741.0000 shares
Direct holdings of common stock following the reported Form 4 transactions
RSUs remaining after vesting
14545.0000 units
Restricted stock units outstanding after the 3,636-unit conversion
RSU grant year
2024
Year of the RSU award under the Tandem Diabetes Care 2023 Long-Term Incentive Plan
Key Terms
Restricted Stock Unit, tax withholding requirements, Long-Term Incentive Plan, contingent right
4 terms
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" with underlying common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding requirements financial
"Shares withheld by the Issuer to satisfy tax withholding requirements"
Long-Term Incentive Plan financial
"pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
contingent right financial
"Each RSU represents a contingent right to receive either one share of common stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did TNDM executive Jean-Claude Kyrillos report?
Jean-Claude Kyrillos reported 3,636 RSUs converting into common stock and 1,926 shares withheld by Tandem Diabetes Care for taxes at $15.28 per share. His direct holdings rose to 31,741 common shares, with 14,545 RSUs still outstanding.
What happened to the restricted stock units in the TNDM COO’s grant?
On July 15, 2026, 3,636 RSUs converted into an equal number of common shares, reducing the RSU balance to 14,545 units. The RSUs come from a July 2024 grant under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan.
Was the TNDM COO’s Form 4 transaction under a Rule 10b5-1 plan?
The Form 4 indicates the Rule 10b5-1 checkbox was not marked, and the footnotes do not reference any trading plan. The activity relates to RSU vesting and tax withholding, rather than an open-market trading program.
What are the key terms of the TNDM COO’s RSU award mentioned in the Form 4?
The RSUs were awarded in July 2024 under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan. Each RSU represents a contingent right to receive one share of common stock or cash in lieu, at the company’s discretion, subject to the plan’s vesting schedule.